Cargando…
Mesenchymal Stromal Cells for Transplant Tolerance
In solid organ transplantation lifelong immunosuppression exposes transplant recipients to life-threatening complications, such as infections and malignancies, and to severe side effects. Cellular therapy with mesenchymal stromal cells (MSC) has recently emerged as a promising strategy to regulate a...
Autores principales: | Podestà, Manuel Alfredo, Remuzzi, Giuseppe, Casiraghi, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559333/ https://www.ncbi.nlm.nih.gov/pubmed/31231393 http://dx.doi.org/10.3389/fimmu.2019.01287 |
Ejemplares similares
-
Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
por: Podestà, Manuel Alfredo, et al.
Publicado: (2021) -
Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
por: Perico, Norberto, et al.
Publicado: (2018) -
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
por: Casiraghi, Federica, et al.
Publicado: (2019) -
Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis
por: Salfi, Giuseppe, et al.
Publicado: (2023) -
Editorial: Global excellence in translational immunology: Europe
por: Casiraghi, Federica, et al.
Publicado: (2023)